Miriam Simón-Fuentes

Miriam Simón-Fuentes

Auto-generated profile, based on publicly available information

Miriam Simón-Fuentes

Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
MSMiriam Simón-Fuentes
Miriam Simón-Fuentes
IRIsrael Ríos
Israel Ríos
CHCristina Herrero
Cristina Herrero
FLFATIMA LASALA
FATIMA LASALA
NLNuria Labiod
Nuria Labiod
ÁDÁngeles Domínguez-Soto
Ángeles Domínguez-Soto
Monocyte-derived macrophages, the major source of pathogenic macrophages in COVID-19, are oppositely instructed by macrophage CSF (M-CSF) or granulocyte macrophage CSF (GM-CSF), which promote the generation of antiinflammatory/immunosuppressive MAFB + (M-MØ) or proinflammatory macrophages (GM-MØ), respectively. The transcriptional profile of prevailing macrophage subsets in severe COVID-19 led us to hypothesize that MAFB shapes the transcriptome of pulmonary macrophages driving severe COVID-19 pathogenesis. We have now assessed the role of MAFB in the response of monocyte-derived macrophages to SARS-CoV-2 through genetic and pharmacological approaches, and we demonstrate that MAFB regulated the expression of the genes that define pulmonary pathogenic macrophages in severe COVID-19. Indeed, SARS-CoV-2 potentiated the expression of MAFB and MAFB-regulated genes in M-MØ and GM-MØ, where MAFB upregulated the expression of profibrotic and neutrophil-attracting factors. Thus, MAFB determines the transcriptome and functions of the monocyte-derived macrophage subsets that underlie pulmonary pathogenesis in severe COVID-19 and controls the expression of potentially useful biomarkers for COVID-19 severity.